COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Strategic Alliance Between Xlife Sciences AG, JIPYONG LLC and JIPYONG IP to Accelerate Korean Life Sciences Ventures’ Access to Global Capital Markets
Xlife Sciences AG partners with JIPYONG LLC and JIPYONG IP to boost Korean life sciences ventures' access to global capital markets. Strategic alliance to enhance global market positioning -
-
-
COMMUNIQUÉ DE PRESSE
Xlife Sciences AG Announces Strategic Collaboration between Portfolio Company Firstgene Life Sciences and Hovione in the Field of Gene Therapy
Xlife Sciences AG announces strategic collaboration between Firstgene Life Sciences and Hovione in the field of Gene Therapy for Hepatocellular carcinoma treatment, expanding into gene therapy market -
-
-
COMMUNIQUÉ DE PRESSE
Xlife Sciences AG confirms sustainable value development and strategic scaling of the portfolio in the 2024 Valuation Report
Xlife Sciences AG confirms sustainable value development and strategic scaling of the portfolio in the 2024 Valuation Report. Key parameters include rNPV, cost of capital, and development risks
